TREATMENT OF VERTIGO- WITH & WITHOUT ANXIOLYTIC DRUG (ALPRAZOLAM 0.25MG)

• Published in: Pakistan Armed Forces medical journal Vol. 71; no. Suppl-3; pp. S445 - 47
• Main Authors: Ayub, Muhammad Waqas, Bukhari, Syed Muhammad Asad Shabbir, Raza, Mohsin, Waqas, Asma, Khan, Beenish Hassan, Najam, Atif
• Format: Journal Article
• Language: English
• Published: Knowledge Bylanes 31.12.2021
• Subjects: Alprazolam; Patient satisfaction; Vertigo
• ISSN: 0030-9648; 2411-8842
• DOI: 10.51253/PAFMJ.V1I1.7922

Objective: To compare the effect of using the tablet Alprazolam 0.25mg in the treatment outcome of vertigo related anxiety by beck anxiety inventory. Study Design: Comparative study. Place and Duration of Study: Combined Military Hospital Okara Cantt, Sep 2018 to Jun 2020. Methodology: A total of 384 patients were included in the study. They were randomly assigned to group A and B by randomized clinical trial. Group A was given tablet alprazolam 0.25 mg along with the conventional treatment of vertigo and group B was given the treatment of vertigo only and no anxiolytic was added. Their pre & post treatment (after 2 weeks) anxiety level using Beck anxiety inventory was scored. Results: There was a significant improvement in group A patient’s vertigo effects after treatment with alprazolam. Also, it was observed that group A patients responded significant improvement in anxiety score as compared to Group B patients 02 weeks post treatment. Conclusion: Antianxiety treatment should be added in all cases with the conventional treatment of vertigo to reduce the vertigo associated anxiety of the patients.